Peptide Therapeutics intermediate
ATSP-7041 - MDM2/MDMX (NCT04022877)
Phase II trial of ATSP-7041 for MDM2/MDMX-driven cancers. This peptide or oligopeptide is studied for its biological activity, structure-activity relationshi...
By Encyclopeptide Editorial | 1 min read
atsp-7041-mdm2-mdmx-nct04022877 peptide research
Overview
Phase II trial of ATSP-7041 for MDM2/MDMX-driven cancers.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “ATSP-7041 - MDM2/MDMX (NCT04022877)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about ATSP-7041 - MDM2/MDMX (NCT04022877) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept